Atopik Dermatit

1. Leung
DY,Thar
p M, Boguniewicz M. Atopic dermatitis. In:Fitzpatrick TB, Eisen AZ, Wolf K, Freedberg IM, Austen KF. Fitzpatrick's Dermatology In General Medicine 5th ed Newyork, Mc Graw Hill, 1999;1464-80.
2. Brehler RB, Luger TA. Atopic dermatitis: The role of pity-rosporum ovale. J Eur Acad Dermatol Venereol. 2001;15(1):5-6.
3. Kristal L. Atopic dermatitis in infants and children. An
update. Pediatr Clin North Am. 2000;47(4):877-95.
4. Hanifin JM, Chan S. Biochemical and immunologic mech¬anisms in atopic dermatitis: new targets for emerging ther¬apies. J Am Acad Dermatol. 1999;41(1):72-7.
5. Meagher LJ, Wines NY, Cooper AJ. Atopic dermatitis: review of immunopathogenesis and advances in immuno-suppressive therapy.
Australas J Dermatol. 2002;43(4):247-54.
6. Uehara M, Kimura C. Descendant family history of atopic dermatitis. Acta Derm Venereol. 1993;73(1):62-3.
7. Jaffe R. Atopic dermatitis . Primary Care. 2000;27(2):503-
13.
8. Thestrup-Pedersen K. Atopic dermatitis: summary of the 1st Georg Rajka symposium 1998 and a literature review.
S.D.Ü. Tıp Fak. Derg. 2004;11(2):21-25
Yıldırım,
Atopi
k Dermatit
25
Acta Derm Venereol. 1999; 79(4): 257-64.
9. Diepgen TL. Atopic dermatitis: The role of environmental and social factors the European experience. J Am Acad
Dermatol. 2001;45(1 Suppl):S44-8.
10. Olesen BA. Role of the early environment for expression of atopic dermatitis. J Am Acad Dermatol. 2001;45(1 Suppl):S37-40.
11. Lugovic L, Lipozenocic J, Jakic-Razumovic J. Atopic der¬matitis: immunophenotyping of inflammatory cells in skin
lesions. Int J Dermatol. 2001.40:489-94.
12. Aksungur V. Atopik Dermatit. In: Oğuz O, Serdaroğlu S.
Dermatolojide Gelişmeler 3. İstanbul, 1998;87-100.
13.
Gülmezoğl
u E, Ergüven S. Lenfoid hücrelerin bireysel gelişmesi. İmmunoloji 1. Baskı Ankara, Feryal Matbaası, 1994;119-116.
14. Watanabe K, Kondo N, Fukutomi O. Characterization of infiltrating CD4+cells in atopic dermatitis CD45R and CD29 monoclonal antibodies. Ann Allergy. 1994;
72(1):39-44
15. Eedy DJ. What's new in atopic dermatitis? Br J Dermatol. 2001;145(3): 380-4.
16. Leung DY. Pathogenesis of atopic dermatitis. J Allergy Clin Immunol. 1999;104(3 Pt 2):S99-108.
17. Hamid Q, Boguniewicz M, Leung D. Differential in situ cytokine gene expression in acute versus chronic atopic der¬matitis. J Clin Invest. 1994;94(2):870-6.
18. Halbert AR, Weston WL, Morelli JG. Atopic dermatitis: is it an allergic disease?
J Am Acad Dermatol. 1995;33(6):1008-18.
19. Banfield CC, Callard RE, Harper JI. The role of cuta¬neous dendritic cells in the immunopathogenesis of atopic dermatitis. Br J Dermatol. 2001;144(5):940-6.
20. Stingl G. IgE-mediated, Fc(epsilon)RI-dependent allergen presentation: a pathogenetic factor in atopic dermatitis? J Am Acad Dermatol. 2001;45(1 Suppl):S17-20.
21. Schmid-Grendelmeier P, Simon D, Simon HU, Akdis CA, Wuthrich B. Epidemiology, clinical features, and immunol¬ogy of the "intrinsic" (non-IgE-mediated) type of atopic dermatitis (constitutional dermatitis). Allergy. 2001;56(9):841-9.
22. Reitamo S. Tacrolimus : A new topical immunomodulato-ry therapy for atopic dermatitis. J Allergy Clin Immunol. 2001;107(3):445-8.
23. Imokawa G. Lipid abnormalities in atopic dermatitis. J
Am Acad Dermatol. 2001;45(1 Suppl):S29-32.
24. Horrobin DF. Essential fatty acid metabolism and its mod¬ification in atopic eczema. Am J Clin Nutr. 2000;71(1
Suppl):367S-72S.
25. Soyland E, Funk J, Rajka G, Sandberg M, Thune P, Rustad L, Helland S, Middelfart K, Odu S. Dietary supple¬mentation with very long-chain n-3 fatty acids in patients with atopic dermatitis. A double-blind, multicentre study. Br J Dermatol. 1994;130(6):757-64.
26. Ruzicka T. Atopic eczema between rationality and irra¬tionality. Atopic eczema between rationality and irrational¬ity. Arch Dermatol. 1998;134(11):1462-9.
27. Savaşkan H. Atopik dermatit. In: Tüzün Y, Kotoğyan A, Aydemir EH, Baransü O. Dermatoloji 1. Baskı İstanbul,
Cem Ofset Matbaacılık, 1994;257-265.
28. Baykal C. Atopik dermatit. Dermatoloji Atlası 1. Baskı
ARGOS
İletişi
m Hizmetleri 2000;189-92.
29. Odom RB, James WD, Berger TG. Atopic dermatitis, eczema, and non infectionus immuno deficiency disorders. Andrews' disease of the skin 9th ed Philadelphia, W.B. Saunders Company, 2000;69-76.
30. Thestrup-Pedersen K. Clinical aspects of atopic dermati¬tis. Clin Exp Dermatol. 2000;25(7):535-43
31. Aksungur VL. Atopik dermatit. In: Aksungur VL, Acar MA. Deri sorunlarında basamak basamak tanı ve öneriler 1. Baskı Adana, 5G Matbaacılık, 1999;186-8.
32. Hanifin JM, Tofte SJ. Update on therapy of atopic der¬matitis. J Allergy Clin Immunol. 1999;104(3 Pt 2):S123-5.
33. Correale CE, Walker C, Murphy L, Craig TJ. Atopic der¬matitis: A review of diagnosis and treatment. Am Fam Physician. 1999;60(4):1191-8, 1209-10.
34. Stephens RB, Cooper A. The caseload, assessment and treatment of atopic dermatitis: a survey of Australian der¬matologists. Australas J Dermatol. 1999;40(4):187-9.
35. İçke İ, Başak PY. Atopik dermatitte tedavi yaklaşımları: Sistemik inceleme. T Klin J Allergy- Asthma 2002;4:149-56.
36. Kimata H, Hiratsuka S. Effect of topical cromoglycate solution on atopic dermatitis: combined treatment of sodi¬um cromoglycate solution with the oral anti-allergic med¬ication, oxatomide. Eur J Pediatr. 1994;153(2):66-71.
37. Sidbury R, Hanifin JM. Old, new, and emerging therapies for atopic dermatitis. Dermatol Clin. 2000;18(1):1-11.
38. Dicarlo JB, McCall CO. Pharmacologic alternatives for severe atopic dermatitis. Int J Dermatol. 2001
Feb;40(2):82-8.
39. Hannuksela M, Kalimo K, Lammintausta K, Mattila T, Turjanmaa K, Varjonen E, Coulie PJ. Dose ranging study: cetirizine in the treatment of atopic dermatitis in adults. Ann
Allergy. 1993;70(2):127-33.
40. Veien NK, Kaaber K, Larsen PO, Nielsen AO, Thestrup-Pedersen K. Ranitidine treatment of hand eczema in patients with atopic dermatitis: a double-blind, placebo-controlled trial. J Am Acad Dermatol. 1995;32(6):1056-7.
41. Lear JT, English JS, Jones P, Smith AG. Retrospective review of the use of azathioprine in severe atopic dermati¬tis. J Am Acad Dermatol. 1996;35(4):642-3
42. Sidbury R, Hanifin JM. Systemic therapy of atopic der¬matitis.
Clin Exp Dermatol. 2000;25(7):559-66.
43. Grundmann-Kollmann M, Podda M, Ochsendorf F, Boehncke WH, Kaufmann R, Zollner TM. Mycophenolate mofetil is effective in the treatment of atopic dermatitis. Arch Dermatol. 2001 Jul;137(7):870-3.
44. Yanase DJ, David-Bajar K. The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis. J Am Acad Dermatol. 2001;44(1):89-93.
45. Leroy BP, Boden G, Lachapelle JM, Jacquemin MG, Saint-Remy JM. A novel therapy for atopic dermatitis with allergen-antibody complexes: a double-blind, placebo-con¬trolled study. J Am Acad Dermatol. 1993;28(2 Pt 1):232-9.